MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Meet the Robot That Can Help Perform Angioplasty Robocath
R-One is designed to optimize the safety of robotic-assisted coronary angioplasty. The system is also designed to protect the physician and other medical staff from radiation exposure by allowing the robot to be controlled by a joystick from the control unit, which is separated from the robotic unit by a protection screen.

Meet the Robot That Can Help Perform Angioplasty

R-One is the first European robotic solution to obtain the CE mark in the field of interventional cardiology.

There's a new surgical robot on the market in Europe and the Middle East, and this one can assist in stenting procedures such as angioplasty. Rouen, France-based Robocath developed R-One, which is the first European robotic solution to obtain the CE mark in the field of interventional cardiology.

R-One is designed to enable precision technologies that complement existing methods, in order to improve procedures and the working environment. The company said the device uses a unique technology that optimizes the safety of robotic-assisted coronary angioplasty. The R-One has an open architecture so it is compatible with market-leading devices and cath labs.

The system is comprised of a radio-protected control unit and a robotic unit. The control station includes a screen designed to protect medical staff from radiation exposure while using joysticks to operate the robotic unit on the other side of the screen.

"Our entry into the market for interventional vascular robotics represents a substantial opportunity for growth," said Philippe Bencteux, MD, chairman and founder of Robocath. "There is the potential for the R-One solution to be installed in more than 3,000 procedure rooms, performing around 1.6 million interventions each year in Europe alone. Building on our CE mark, we expect to finalize a number of strategic distribution partnerships very shortly in high potential geographic areas, with a Europe and Middle East-wide launch expected in 2020.”

Bencteux founded Robocath in 2009. In developing the robot, Bencteux told MD+DI that the challenge Robocath was faced with was that the robot had to be very precise, very user-friendly, very affordable, and also universal (compatible with existing devices).

"The most important issues of robotics today is price and time consumption and I think we developed a really time- and cost-efficient robotic solution," Bencteux said.

Bencteux said Robocath as a company has been quite agile and spent only 10 million euros to get the robot through the CE mark process. The company is planning a new fundraising campaign, with support from its existing investors, to support the full commercial launch of R-One and to develop the next generation of the robot.

TAGS: News
Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.